Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 6Gliosarcoma 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Pinealoma 2Medulloblastoma 2Glioma 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningioma 1Glioma, Subependymal 1Ganglioneuroblastoma 1Fallopian Tube Neoplasms 1Ependymoma 1Craniopharyngioma 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Astrocytoma 1

Interventions

Gemcitabine 2Taxes 1Radiotherapy, Conformal 1Metformin 1Ethiodized Oil 1Albumin-Bound Paclitaxel 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pancreatic Adenocarcinoma × Radiotherapy, Conformal × Clear all
NCT00288093 2017-08-18

3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡